Utilization Patterns of Single-Fraction and Short- Course Radiotherapeutic Schedules in the Management of Bone Metastases

被引:1
|
作者
Koduri, Sravya [1 ]
Abel, Stephen [2 ]
Bergin, John [2 ]
Fuhrer, Russell [2 ]
Beriwal, Sushil [2 ]
Wegner, Rodney E. [2 ]
机构
[1] Lankenau Med Ctr, Dept Med, Philadelphia, PA USA
[2] Allegheny Hlth Network Canc Inst, Div Radiat Oncol, Pittsburgh, PA 15224 USA
关键词
D O I
10.1016/j.adro.2023.101176
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Bone metastases are common, occurring in 60% to 70% of patients with advanced malignancies. Historically, bone-directed radiation therapy regimens of 30 Gy over 10 fractions were used. However, prospective randomized data suggest equivalent pain relief with shorter-course regimens. The American Society for Radiation Oncology Choosing Wisely Campaign encourages clinicians to consider shorter-course palliative regimens in patients with limited prognosis. A retrospective analysis was performed to assess patterns of short-course and single-fraction radiation therapy during the past 5 years.Methods and Materials: We queried our electronic medical record (MOSAIQ) from 2016 to 2020 for patients with bone metastases who received palliative radiation therapy. Patients receiving >10 fractions or Medicare-approved palliative courses of radiation (30 Gy/10 fractions, 24 Gy/6 fractions, 20 Gy/5 fractions, 8 Gy/1 fraction) were included. Treatment department was defined as academic (n = 2) versus community (n = 12). Short-course treatment was defined as <6 fractions, whereas long-course included patients receiving >10 fractions. Patients were subdivided based on age and disease site. Physicians were grouped according to their year of residency completion. Multivariable logistic regression analysis identified predictors of short-course and single-fraction treatment.Results: We identified 1004 patients with 1768 bony metastases meeting inclusion criteria. The spine was the most common site, followed by pelvis/hip, extremity, and other site. Use of short-course treatment increased from 40% in 2016 to 50% in 2020. Single-fraction treatment increased from 7% in 2016 to 11% in 2020. Predictors of shorter courses included treatment at academic centers, more recent treatment, patient age >76 years, and nonspine anatomic site. Predictors of single-fraction treatment included treatment at academic centers, treating physician residency completion after 2010, patient age >76 years, and treatment to extremity or other site.Conclusions: Rates of short-course and single-fraction bone-directed radiation therapy increased within our health system over time. Treatment receipt at academic centers was associated with both short-course and single-fraction regimens. Physicians completing residency after 2010 were more likely to deliver single-fraction therapy.(c) 2023 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:5
相关论文
共 48 条
  • [21] Assessment of National Practice for Palliative Radiation Therapy for Bone Metastases Suggests Marked Underutilization of Single-Fraction Regimens in the United States
    Rutter, Charles E.
    Yu, James B.
    Wilson, Lynn D.
    Park, Henry S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 91 (03): : 548 - 555
  • [22] Efficacy and tolerability of single-fraction radiotherapy for spinal bone metastases in a low-middle-income country setting: a prospective study
    Hossain, Altaf
    Galietta, Erika
    Uddin, Afm Kamal
    Zamfir, Arina A.
    Hossain, Nowshin Taslima
    Hossain, Tasneem
    Hussain, Qazi Mushtaq
    Morganti, Alessio G.
    Bhuiyan, Md Rahmatullah
    SUPPORTIVE CARE IN CANCER, 2025, 33 (01)
  • [23] 8 Gy single-fraction radiation for bone metastases: Do the data support a 1-size-fits-all approach?
    Gonzalez, Victor J.
    Howell, Krisha
    PRACTICAL RADIATION ONCOLOGY, 2017, 7 (01) : 16 - 18
  • [24] Pain response after high dose single-fraction IMRT for patients with spinal bone metastases-a randomized controlled trial
    Sprave, T.
    Forster, R.
    Schlampp, I.
    Hees, K.
    Bruckner, T.
    Bostel, T.
    Welte, S.
    Tonndorf-Martini, E.
    Nicolay, N.
    Debus, J.
    Rief, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S66 - S66
  • [25] Impact of a Dedicated Palliative Radiation Oncology Service on the Use of Single-Fraction and Hypofractionated Radiation Therapy Among Patients With Bone Metastases
    Agarwal, I.
    Makar, M.
    Noveroske, S.
    Krishnan, M. S.
    Taylor, A.
    Gorman, D.
    Balboni, T. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S63 - S64
  • [26] Comparison of two multifraction radiotherapy schedules in management of painful bone metastases: A single institution prospective study
    Jamre, R.
    Ghori, H.
    Singh, O.
    Tiwari, V
    Shrivastava, A.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2019, 22 (11) : 1539 - 1545
  • [27] Impact of Using Audit Data to Improve the Evidence-Based Use of Single-Fraction Radiation Therapy for Bone Metastases in British Columbia
    Olson, Robert A.
    Tiwana, Manpreet
    Barnes, Mark
    Cai, Eric
    McGahan, Colleen
    Roden, Kelsey
    Yurkowski, Emily
    Gentles, Quinn
    French, John
    Halperin, Ross
    Olivotto, Ivo A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (01): : 40 - 47
  • [28] Single-Fraction Stereotactic versus Conventional Multifraction Radiation for Predominantly Non-Spine Bone Metastases: A Randomized Phase II Trial
    Nguyen, Q. N.
    Chow, E.
    Chun, S. G.
    Komaki, R. U.
    Liao, Z.
    Fnu, R. Z.
    Szeto, B.
    Hahn, S. M.
    Fuller, C. D.
    Moon, B.
    Lin, P.
    Bird, J.
    Satcher, R.
    Jeter, M. D.
    O'Reilly, M. S.
    Lewis, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S49 - S49
  • [29] Do Coordinated Knowledge Translation Campaigns Persuade Radiation Oncologists to Use Single-Fraction Radiation Therapy Compared With Multiple-Fraction Radiation Therapy for Bone Metastases?
    Shahhat, Shaheer
    Hanumanthappa, Nikesh
    Chung, Youn Tae
    Beck, James
    Koul, Rashmi
    Bashir, Bashir
    Cooke, Andrew
    Dubey, Arbind
    Butler, Jim
    Nashed, Maged
    Hunter, William
    Rathod, Shrinivas
    Ong, Aldrich
    Tran, Kim
    Kim, Julian O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (02): : 365 - 373
  • [30] Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial
    Quynh-Nhu Nguyen
    Chun, Stephen G.
    Chow, Edward
    Komaki, Ritsuko
    Liao, Zhongxing
    Zacharia, Rensi
    Szeto, Bill K.
    Welsh, James W.
    Hahn, Stephen M.
    Fuller, C. David
    Moon, Bryan S.
    Bird, Justin E.
    Satcher, Robert
    Lin, Patrick P.
    Jeter, Melenda
    O'Reilly, Michael S.
    Lewis, Valerae O.
    JAMA ONCOLOGY, 2019, 5 (06) : 872 - 878